Form 8-K - Current report:
SEC Accession No. 0001144204-16-125648
Filing Date
2016-09-28
Accepted
2016-09-28 08:30:57
Documents
1
Period of Report
2016-09-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K v449517_8k.htm 8-K 16785
  Complete submission text file 0001144204-16-125648.txt   17963
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 161905746
SIC: 2834 Pharmaceutical Preparations